You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed Refractory B-cell Acute Lymphoblastic Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • QH103 Cell Injection
  • +2 more
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Sep 21, 2023

B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • (no location specified)
Oct 10, 2023

Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

Not yet recruiting
  • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
  • Inotuzumab Ozogamicin
  • (no location specified)
Nov 3, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Nanchang (Human CD19 Targeted DASH CAR-T Cells Injection)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Human CD19 Targeted DASH CAR-T Cells Injection
  • Nanchang, Jiangxi, China
    The Second Affiliated Hospital of Nanchang University
Dec 13, 2022

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

Refractory B-cell Acute Lymphoblastic Leukemia Trial in Houston (Mosunetuzumab)

Not yet recruiting
  • Refractory B-cell Acute Lymphoblastic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2023

B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

Not yet recruiting
  • B Precursor Acute Lymphoblastic Leukemia
  • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 25, 2023

Relapse Leukemia, Refractory Leukemia Trial in Shenzhen (Allogeneic CD19 CAR-T cells)

Recruiting
  • Relapse Leukemia
  • Refractory Leukemia
  • Allogeneic CD19 CAR-T cells
  • Shenzhen, Guangdong, China
    Li Yu
Dec 7, 2021

PET-CT Imaging in Relapsed/Refractory Acute Leukemias

Not yet recruiting
  • B Cell
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 4, 2023

    B-Cell Acute Lymphoblastic Leukemia, Adult Trial in La Jolla, Orange, San Francisco (blinatumomab, pembrolizumab)

    Terminated
    • B-Cell Acute Lymphoblastic Leukemia, Adult
    • La Jolla, California
    • +2 more
    Apr 26, 2022

    B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

    Recruiting
    • B-Cell Non Hodgkin Lymphoma
    • B-Cell Acute Lymphoblastic Leukemia
    • anti-CD19 CAR T-cells
    • Hanoi, Vietnam
      Vinmec Research Institute of Stem Cell and Gene Technology
    Sep 5, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CD19 specific Chimeric Antigen Receptor T Cell
    • Columbus, Ohio
      Nationwide Children's Hospital
    Mar 9, 2023

    Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

    Recruiting
    • Non-hodgkin Lymphoma
    • +2 more
    • CC312
    • Tianjin, Tianjin, China
      InstituteHBDH
    Sep 12, 2023

    CAR, Refractory Acute Lymphoblastic Leukemia, Relapsed Adult ALL Trial in Suzhou (Treatment)

    Recruiting
    • CAR
    • +2 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 27, 2022

    B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, Unspecified Trial in Guangzhou, Guanzhou (CD19 CAR T-Cell(CAT19T2))

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-Cell Lymphoma, Unspecified
    • CD19 CAR T-Cell(CAT19T2)
    • Guangzhou, Guangdong, China
    • +1 more
    Nov 4, 2022

    Acute Lymphocytic Leukemia Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor (CAR) T Cells)

    Recruiting
    • Acute Lymphocytic Leukemia
    • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
    • Tianjin, Tianjin, China
      Hematology Hospital, Chinese Academy of Medical Sciences
    Feb 5, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (single dose of CNCT19)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • single dose of CNCT19
    • (no location specified)
    Dec 19, 2022

    Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19

    Recruiting
    • Lymphoblastic Leukemia
    • +5 more
    • Anti-CD19 CAR T-cells
    • Singapore, Singapore
    • +1 more
    Dec 4, 2022

    ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

    Not yet recruiting
    • ALL, Childhood B-Cell
    • +2 more
    • Tafasitamab
    • (no location specified)
    Nov 25, 2022

    B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (U-CAR-T Cells (LstCAR019))

    Withdrawn
    • B-cell Acute Lymphoblastic Leukemia
    • B-ALL
    • U-CAR-T Cells (LstCAR019)
    • Kunming, Yunnan, China
      Kunming Hope of Health Hospital
    Nov 27, 2022

    Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial (ThisCART19A, Fludarabine Oral Tablet, Cyclophosphamide)

    Not yet recruiting
    • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
    • (no location specified)
    Oct 8, 2022

    B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (UCAR-T Cells)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-ALL
    • UCAR-T Cells
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Dec 7, 2022

    Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia Trial in Beijing

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • chimeric antigen receptor T cell
    • Beijing, Beijing, China
      Beijing Boren Hospital
    Aug 12, 2022

    Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • cladribine, cytarabine,venetoclax
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 22, 2022